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Objective: To evaluate the nutritional status of crack users and to analyze its correlation with drug
use profiles.
Methods: Cross-sectional study with 108 crack users. Anthropometric data were assessed through
body mass index (BMI) and bioimpedance (BIA) measurements. A blood test to analyze hematocrit,
hemoglobin, glucose, and lipid profiles was also performed. Crack use was determined through a
standardized interview.
Results: Based on BMI and BIA, most individuals were eutrophic (about 70%). Regarding hemato-
logical parameters, we found that hemoglobin and hematocrit levels were below normal for 32.4 and
30.6% of patients, respectively. Considering normal parameters, a large part of the sample (60.2%)
had low levels of HDL cholesterol and high levels of triglycerides (38%). There were no significant
correlations between drug profile and nutritional variables.
Conclusion: This is a pioneering study that examines the nutritional status of crack users. Our results
showed that most crack users present normal anthropometric findings and the prevalence of under-
weight is low. However, blood analysis showed changes and a specific type of malnutrition.
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Introduction
Crack cocaine (crack), a smoked form of cocaine, is a
highly addictive and powerful stimulant that became popular
in the mid-1980s and has been used worldwide ever
since.1,2 Brazil is considered the world’s largest consumer
of crack, with approximately 1.7 million regular users.3,4
Recently, an epidemiological study estimated a preva-
lence of 0.81% of regular crack-cocaine users in Brazilian
capitals, corresponding to 35% of all illicit drug users apart
from marijuana.4 Although rates of crack use are lower
than those of other drugs, it has been observed that this
illicit drug leads to more psychiatric hospitalizations and
causes a greater demand for care.5
Crack use stimulates the central nervous system and
activates the brain’s reward systems by blocking the
presynaptic reuptake of dopamine, norepinephrine, and
serotonin. This increases the availability of these neuro-
transmitters in the synaptic cleft and causes intense
feelings of pleasure.6 Moreover, crack users often abuse
other types of psychoactive substances, mostly alcohol
and tobacco, which can aggravate their clinical and nutritional
status.7,8
The clinical consequences and comorbidities of crack
use have been well described in a number of studies,8-12
but there is a gap in literature regarding the nutritional
profile of crack users. Malnutrition in this population may
be multifactorial and could involve lower caloric intake,
abnormal metabolic and gastrointestinal functions, and
even deleterious drug effects.13 Association between obesity
and stimulant use (such as crack) is rare, since cocaine
and amphetamines are appetite suppressants that tend to
reduce body weight with their anorexic effects.14,15
Several studies have highlighted malnutrition and under-
weight in active multiple-drug users.13,14,16-21 However,
weight gain and binge eating have also been observed in
people recovering from drug and alcohol dependence,
which suggests the possibility that food and drugs may
act on the same brain reward mechanisms.14,22-24 Surpris-
ingly, a pilot study conducted by our group found high
rates of normal-weight and overweight crack users at
hospital admission.25 Considering that overweight is asso-
ciated with multiple medical conditions, including diabetes,
hypertension, and hyperlipidemia, the increased risk of
morbidity and mortality could be particularly harmful when
combined with the use of stimulants such as cocaine.15,26
This study focused on describing the previously-unknown
nutritional profile of crack users, supporting early interven-
tion based on scientific and personalized findings to aid
clinical recovery. Our main hypothesis was that the severity
of crack use may impair nutritional status. Due to the large
number of crack users in Brazil and the increasing
demand for health services, research is needed in this area.
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This study aimed to evaluate the nutritional status of crack
users and analyze its correlation with drug use profiles.
In addition, we compared the performance of different
nutritional assessment methods, such as anthropometric
and biochemical parameters (blood tests).
Methods
Baseline subject characteristics and study design
A total of 108 individuals were consecutively recruited
by convenience between April 2014 and April 2015 at
the Servic¸o de Psiquiatria de Adic¸a˜o of the Hospital de
Clı´nicas de Porto Alegre (HCPA), a large Brazilian teach-
ing hospital affiliated with the Universidade Federal do
Rio Grande do Sul (UFRGS) that provides free public
services. All patients met the criteria for crack addiction
as described by the DSM-5.27 Crack addiction was diag-
nosed through a comprehensive clinical interview per-
formed by a trained psychiatrist in charge of inpatient
admissions. Inclusion criteria were: being a male crack
cocaine user who screened positive for cocaine in a urine
test at admission (Bioeasy® cocaine test, Aleret, Recife,
Brazil); being at least 18 years old; and agreeing to pro-
vide blood samples and a signed informed consent form.
Crack was required to be the drug of choice, but the use
of other psychoactive substances was not an exclusion
criterion. Subjects who presented symptoms compatible
with dementia or psychosis or those who presented cog-
nitive impairment that prevented comprehension of the
study were excluded from the sample. These exclusion
criteria were verified by a psychiatrist in a clinical inter-
view, who used the standard recruitment center evaluation.
Sociodemographic characteristics and drug use profile
The subjects’ socioeconomic status was determined in
accordance with the Brazilian Association of Research
Companies (Associac¸a˜o Brasileira de Empresas e
Pesquisa28) scale. This instrument includes questions
about education, home appliances, housing characteris-
tics, and access to public services to evaluate income
level. Five classes are derived from these indicators:
A (35-42 points); B (23-34 points); C (14-22 points);
D (8-13 points); and E (0-7 points). Class A is the most
advantaged, while class E is the poorest.
Crack use was determined through a standardized inter-
view, using a questionnaire that included items related
to the type, mode, and frequency of drug use. Severity
of crack use was estimated by age of first use, years
of use, and crack rocks used in the previous 30 days, as
described in previous studies.29-31 First crack use at the
age of 11 was considered as 10 points, with a reduction
of 1 point per year until age 20 (1 point) and 0 points for
age 21 or older; 1 point was given for each year of per year
crack use. The number of crack rocks used in the last
30 days was valued as follows: 1-5 = 1 point, 6-21 = 2 points,
22-40 = 3 points, 41-72 = 4 points, 73-103 = 5 points, 104-
142 = 6 points, 142-200 = 7 points, 201-343 = 8 points,
344-515 = 9 points, and 516 or more = 10 points. The sum
of these three variables was used to produce a crack use
severity score, and the participants were categorized into
a more severe or less severe group, which were divided
by the median.
Daily alcohol consumption in the last 30 days was
also assessed. Users mentioned the ingestion of only two
types of beverage: cachac¸a (a distilled spirit made from
fermented sugarcane juice, the most popular distilled alco-
holic beverage in Brazil, with around 44% alcohol) and
beer. For the statistical analyses, we used World Health
Organization (WHO)32 parameters, whereby 350 mL of
beer or 30 mL of spirits correspond on average to 12 g of
alcohol. We calculated the amount (in grams) of ethanol
consumed daily. Data on the number of tobacco and
marijuana cigarettes smoked in the last 30 days was also
obtained in the clinical interview.
Anthropometry and body composition
The anthropometric evaluation was performed within
48 hours of admission. Weight and height were verified
using an LD1050 scale (Lı´der®, Sa˜o Paulo, Brazil) with
50 g precision and with a built-in stadiometer to determine
body mass index (BMI) (weight in kg/height in m2). BMI
was classified according to WHO cutoff points.33 Body
composition (body fat percentage) was analyzed with
tetrapolar bioimpedance (BIA) (Maltron BF 906, Maltron®,
Rayleigh, UK). The test was administered according to
manufacturer instructions, with patients having avoided
exercise in the previous 12 hours, having fasted between
2 to 3 hours, and having their last urine elimination
30 minutes prior to the test. We used American Council
on Exercise parameters to classify individuals based on
body fat.34
Blood tests
Fasting blood samples were obtained for blood test anal-
ysis the morning after admission. Hematocrit and hemo-
globin were analyzed with a Sysmex HST-402 (Sysmex,
Hyo¯go, Japan) platform that uses photometry and flow
cytometry. For glucose and lipids (total cholesterol, HDL
cholesterol, LDL cholesterol, triglycerides), we used the
enzyme assay method in a Cobas c702 analyzer (Roche,
Basel, Switzerland). We measured the hematocrit and
hemoglobin levels using the reference values proposed
by Hoffbrand,35 and the glucose and lipid profiles were
based on references established by the Brazilian Society
of Cardiology.36 Human immunodeficiency virus (HIV)
testing was performed on all patients using the immuno-
blot technique with HIV-1 and HIV-2 antigens. Student’s
t-test was used to verify the difference in variables
between HIV-positive and HIV-negative individuals. Since
there were no significant differences between groups,
all individuals were recruited for the sample.
Ethics
This study was approved by the research ethics com-
mittee of the HCPA/UFRGS (project no. 140146). Data
were collected after each individual was informed of the
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procedures and objectives and gave permission to partici-
pate by signing an informed consent form.
Statistical analysis
The Kolmogorov-Smirnov method (with Lilliefors signifi-
cance correction) was used to verify the normality of the
variables. For the descriptive analysis, we used mean
and standard deviation or median and interquartile range.
The Pearson and Spearman tests were used for correla-
tions and the Mann-Whitney U test and Student’s t-test
were used to compare groups. Statistical analysis was
processed in SPSS version 18.0.
Results
As shown in Table 1, we assessed the subjects’ baseline
characteristics. Users were mostly Caucasian and came
from poor socioeconomic backgrounds. Considering their
BMI and BIA, few individuals were underweight or had low
body fat; most were eutrophic, overweight, or obese.
The blood tests presented in Table 2 show that the
patients’ hemoglobin and hematocrit levels were below
normal in approximately 30% of the sample, and a large
part of the sample had low levels of HDL cholesterol and
high levels of triglycerides. LDL cholesterol, total choles-
terol, and glucose also presented alteration, but at lower
percentages. HIV prevalence was 11.1%.
Table 3 shows the participants’ drug use profiles (crack,
alcohol, marijuana, and/or tobacco). Crack rocks consumed
per day ranged from one to 150 and the consumption period
ranged from four months to 32 years. Sixty-six (61.1%)
patients reported daily consumption of alcoholic beverages
(cachac¸a or beer). Ethanol consumption ranged from
34.28 g to 2,000 g per day. A total of 75.9% of the sub-
jects reported daily use of tobacco cigarettes. A total of
50 individuals (46.29% of the sample) reported marijuana
consumption. Among marijuana users, consumption ranged
from one to 15 cigarettes per day. As a means of evalu-
ating the influence of ethanol on crack consumption,
a Mann-Whitney U test was used to assess the difference
between drinkers (n=66) and non-drinkers (n=42). The
difference between groups was significant (p = 0.040),
demonstrating that individuals who consumed alcohol
used crack less.
There were no significant correlations between crack
consumption and anthropometric measures/blood tests.
The main correlations are presented in Table 4. We found
positive correlations between BMI, BIA, triglycerides,
cholesterol, and glucose.
Using the median crack use severity, we divided the
sample of users into two groups (p 19 and4 19). There was
no significant difference in the nutritional, biochemical, or drug
use variables analyzed between the groups (data not shown).
Discussion
This study provides new insights into the nutritional ass-
essment of drug addicts. Regarding anthropometric para-
meters (BMI and BIA), few individuals presented low weight
Table 1 Sociodemographic and nutritional baseline
characteristics of crack users (n=108)
Variables Reference value n (%)
Age, mean (SD) - 34.51 (9.22)
Race/ethnicity
Caucasian - 80 (74.1)
Black - 28 (25.9)
Socioeconomic class
A/B - 0 (0.0)
C - 5 (4.6)
D/E - 103 (95.4)
BMI (kg/m2)
Underweight o 18.5 6 (5.6)
Normal 18.5-24.9 69 (63.9)
Overweight + obese 4 25.0 33 (30.6)
BIA (body fat %)
Essential fat p 5.0 4 (3.7)
Average/normal 6.0-24.0 84 (77.8)
Obese X 25.0 20 (18.5)
Data presented as n (%), unless otherwise specified.
BIA = tetrapolar bioimpedance; BMI = body mass index;
SD = standard deviation.
BMI was classified according to World Health Organization
cutoff points.33 The subjects’ body fat was classified according
to American Council on Exercise parameters.34
Table 2 Assessment of nutritional parameters using blood
tests (n=108)
Variables/reference value n (%) Mean (SD)
Hematocrit (%) 41.4 (3.6)
40.0-52.0 75 (69.4)
o 40.0 33 (30.6)
Hemoglobin (mg/dL) 14.0 (1.2)
13.5-17.5 73 (67.6)
o 13.5 35 (32.4)
Total cholesterol (mg/dL) 151.2 (36.5)
p 200.0 98 (91.6)
4 200.0 9 (8.4)
HDL cholesterol (mg/dL) 42.2 (14.1)
4 40.0 43 (39.8)
p 40.0 65 (60.2)
LDL cholesterol (mg/dL) 85.9 (29.5)
o 129.0 101 (93.5)
X 129.0 7 (6.5)
Triglycerides (mg/dL) 120.1 (63.1)
o 150.0 67 (62.0)
X 150.0 41 (38.0)
Glucose (mg/dL) 94.4 (34.6)
o 100.0 95 (88.0)
X 100.0 13 (12.0)
HIV
Negative 96 (88.9)
Positive 12 (11.1)
HIV = human immunodeficiency virus; SD = standard deviation.
Hematocrit and hemoglobin levels were measured using the
reference values proposed by Hoffbrand35; glucose and lipid
profiles were based on references established by the Brazilian
Society of Cardiology.36
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and body fat, with most being normal weight, overweight,
or obese. Although a number of studies have reported
malnutrition and underweight in drug users,13,14,16-21
our study found a low prevalence. Nevertheless, this
does not exclude other specific deficiencies. The blood
work revealed important alterations in a significant
proportion of our sample, such as low levels of
hemoglobin and hematocrit, which can be associated
with protein-energy malnutrition and anemia. However,
we found no significant correlations between crack use
variables and any of the nutritional parameters we
evaluated.
In one of the first studies on nutrition in drug addicts,
Santolaria-Ferna´ndez et al.16 demonstrated that 90%
of drug users suffer from protein-energy malnutrition.
Underweight (BMI o 18.5 kg/m2) has already been
demonstrated in multidrug users (60% prevalence)18
and injection drug users (50% prevalence).20 Despite
this, we found no prevalence of low weight. One important
bias is that the other studies involved multiple-drug users
Table 3 Distribution of variables associated with the sample’s drug use profile (n=108)
Variables Mean (SD) Median (IR)
Years of crack use 10.40 (7.01) 9.0 (5.0-14.0)
Crack rocks used (per day) 16.27 (23.90) 8.0 (4.0-15.5)
Age of first crack use 24.10 (8.70) 22.0 (17.0 30.8)
Severity of crack use 19.90 (8.20) 18.5 (14.0-25.0)
Associated drugs (alcohol and tobacco), n (%)
Only crack 5 (4.63) -
Crack + tobacco 17 (15.74) -
Crack + tobacco + alcohol 26 (24.07) -
Crack + tobacco + marijuana 16 (14.81) -
Crack + tobacco + alcohol + marijuana 23 (21.30) -
Crack + alcohol 10 (9.26) -
Crack + alcohol + marijuana 7 (6.48) -
Crack + marijuana 4 (3.70) -
Ethanol (g/day) (n=66) - 400.0 (154.3-800.0)
Comparison of crack use between groups (rocks/day)*
With ethanol (n=66) - 7.0 (3.0-10.0)
Without ethanol (n=42) - 10.0 (6.0-20.0)
IR = interquartile range; SD = standard deviation.
*Mann-Whitney U test, p = 0.040.
Table 4 Correlations between body mass index, bioimpedance, and blood nutritional parameters (n=108)
BIA Hematocrit Hemoglobin TC HDL LDL Glucose Triglycerides
Ethanol
(g/day)
Tobacco
cigarettes/
day
Severity
crack
use
BMI* 0.879
(4 0.001)
-0.019
(0.844)
0.043
(0.659)
0.278
(0.004)
-0.058
(0.548)
0.194
(0.044)
0.171
(0.077)
0.414
(4 0.001)
0.094
(0.336)
-0.054
(0.576)
-0.023
(0.814)
BIA* 1 -0.053
(0.587)
0.020
(0.834)
0.302
(0.001)
-0.035
(0.719)
0.220
(0.022)
0.224
(0.020)
0.380
(4 0.001)
0.086
(0.373)
-0.052
(0.596)
0.058
(0.549)
Hematocrit* 1 0.932
(4 0.001)
0.007
(0.942)
-0.186
(0.055)
0.025
(0.798)
-0.144
(0.137)
0.181
(0.061)
-0.102
(0.293)
0.167
(0.084)
-0.176
(0.068)
Hemoglobin* 1 0.052
(0.596)
-0.184
(0.056)
0.021
(0.830)
-0.095
(0.330)
0.263
(0.006)
-0.071
(0.465)
0.155
(0.108)
-0.152
(0.116)
TCw 1 0.403
(4 0.001)
0.832
(4 0.001)
0.163
(0.091)
0.399
(o 0.001)
0.142
(0.142)
0.031
(0.753)
0.001
(0.991)
HDLw 1 0.146
(0.131)
0.094
(0.334)
-0.341
(o 0.001)
0.326
(0.001)
-0.120
(0.217)
-0.089
(0.362)
LDLw 1 0.080
(0.411)
0.213
(0.027)
-0.078
(0.422)
0.116
(0.230)
-0.004
(0.964)
Glucosew 1 0.183
(0.059)
0.064
(0.510)
-0.052
(0.590)
0.047
(0.627)
Triglyceridesw 1 0.044
(0.649)
0.043
(0.657)
0.023
(0.813)
Ethanol (g/day)w 1 -0.064
(0.512)
0.016
(0.871)
Tobacco
cigarettes/dayw
1 -0.026
(0.786)
Severity crack usew 1
TC = total cholesterol.
Values in bold represent correlations coefficients (r) with p o 0.05.
*Variable with normal distribution.
wVariable with asymmetric distribution.
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from other locations with different drug profiles, usage
types and frequency, while ours included only crack cocaine
users with associated alcohol and tobacco consumption.
Since this is the first study to ever sample such a profile,
we cannot compare it confidently with studies covering
different types of drug users.
There are data on overweight and obesity in recover-
ing drug users, but not in current drug users.14,22-24
For example, Cowan & Devine14 studied drug addicts at
different stages of recovery and reported that most have
poor diets during active addiction, are generally under-
nourished at the beginning of treatment, and become
overweight and obese during recovery. During abstinence,
they may seek alternative ways of activating the brain
reward system and the inhibition of dopamine reuptake,
with one common outlet being overeating.37 To reinforce
this hypothesis, Ersche et al.38 reported that cocaine-
dependent men had a higher food intake than non-users,
specifically foods high in fat and carbohydrates, but had
no concomitant increase in body weight. The authors sug-
gest that this is due to cocaine’s interference with normal
metabolic processes, resulting in an imbalance between
fat intake and storage.
Regarding hematological parameters, we found that
hemoglobin and hematocrit levels were below normal
in 32.4% and 30.6% of patients, respectively. These
decreased levels may indicate protein-energy malnutrition
and anemia. In these cases, anemia may be associated
with a diet poor in micronutrients, especially iron, as
well as insufficient protein intake and clinical problems
(decreased hydrochloric acidproduction, decreased intrin-
sic factor secretion, intestinal perforations, bacterial or
infectious diseases).39 Supporting our findings that BMI
alone is a poor indicator of nutritional status, Nazrul
et al.18 demonstrated that 74% of drug addicts showed
clinical signs of nutrient deficiency, with significantly lower
hemoglobin and total serum protein levels. Meanwhile,
Ross et al.19 found blood markers indicating that 50%
of all subjects had iron or vitamin deficiencies.
Compared to normal parameters, a large proportion of
our sample (60.2%) had low levels of HDL cholesterol and
high levels of triglycerides (38%). LDL cholesterol (6.5%),
total cholesterol (8.4%), and glucose (12%) also pre-
sented alteration, but at lower percentages. This can pro-
bably be ascribed to the subject’s low quality of life, lack
of access to healthy food and physical activity, and high
alcohol consumption. Tang et al.20 studied HIV-positive
and HIV-negative drug addicts and identified other aspects
of nutritional deficiencies, such as food insecurity and low
levels of caloric and protein intake. Our study also found
low levels of HDL, which may be associated with a lack of
social, economic, and physical activities. In a study on
specific deficiencies in multiple-drug users, Nazrul Islam
et al.17 found lower concentrations of antioxidant vitamins
E, C, and A in this population, suggesting a lack of access
to certain foods. The damage and consequences of crack
use can lead to numerous specific nutritional deficiencies
and may require further investigation.
We found positive correlations between BMI, BIA,
triglycerides, cholesterol, and glucose, which reinforces
that body fat is associated with high serum lipid levels and
glucose alterations. Changes in lipid and glucose profiles,
alcohol consumption, and smoking are risk factors for
the development of chronic diseases such as diabetes,
dyslipidemias, hypertension, and metabolic syndrome.
Considering that these individuals are at risk for cardio-
vascular problems due to drug use, the sum of these
factors may increase the probability of disease and
malnutrition.
There was no significant correlation between severity of
crack use and anthropometric or biochemical variables.
However, individuals who consumed alcohol used crack
less (p o 0.05), suggesting a compensatory behavior
involving ethanol. Crack use has been reported to induce
intestinal perforations, gastric ulcerations, retroperitoneal
fibrosis, abdominal pain, nausea, mesenteric ischemia,
and esophagitis, thus impairing absorption, digestion, and
metabolism9 and leading to malnourishment. As for cardio-
vascular consequences, cocaine can cause increased
heart rate and blood pressure, endothelial dysfunction,
arrhythmia, and atherosclerosis. Combining cocaine with
other substances (such as alcohol, marijuana, and/or
tobacco) and other risk factors, such as overweight and
obesity, can cause cumulative health damage.26,40
The high level of alcohol consumption (61%) among
crack users was an unexpected finding. They reported
consuming it in large quantities, mainly in the form of
cachac¸a, exceeding the maximum daily amount of ethanol
(30 g) recommended by the WHO.32 Our results show
high alcohol consumption, indicating that this factor should
also be a concern in the treatment of crack addiction.
The combined use of cocaine/crack and alcohol induces
the biotransformation of cocaine, leading to the transes-
terification of a metabolite, which results in a substance
known as cocaethylene. This increases the duration of
euphoric effects and is more cardiotoxic than consuming
each drug separately.7 We also observed a high pre-
valence of tobacco and marijuana use, with 75.9% and
46.29% of the individuals involved in this behavior, res-
pectively. It has been well documented that smoking can
cause numerous diseases, such as cancer, emphysema,
and cardiovascular diseases. The nutritional effects of
smoking include an increase in free radicals and a decrease
in antioxidants.41 Although crack is much more deleterious
than tobacco or marijuana, the effects of chronic asso-
ciated use can be compounded.
We found that users from classes D and E were mostly
Caucasian, characterizing a low-income population with
little access to education. HIV prevalence in this group is
high (11.1%) compared to the general population, con-
firming that crack users tend to engage in high-risk
behaviors.8,42 These social and clinical factors, when asso-
ciated with crack use, can cause even further damage to
their nutritional status. Since crack use is associated with
complex social issues,43 these individuals could benefit
from lifestyle intervention programs, which have had posi-
tive results in the obese, diabetics, and binge eaters.44-47
Among the present study’s limitations is the fact that
we did not evaluate the impact of alcohol and marijuana
consumption on nutritional status, and our sample con-
sisted exclusively of male subjects. Moreover, we did not
evaluate control subjects, which would have been important
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for comparison with the crack group. We also evaluated
subjects seeking inpatient treatment who, therefore, do
not represent the general population of crack-cocaine
users. However, the present study’s pioneering results
could serve to guide further research on the matter.
In fact, we are already developing a case-control trial
protocol to better elucidate the nutritional profile of crack
users and evaluate the influence of nutritional aspects on
treatment prognosis.
In summary, this was a pioneering study that examined
the nutritional status of crack users. The BMI of most of
them was within the normal, overweight, or obese range.
However, their blood tests indicated alterations in
hematocrit and hemoglobin levels and in glucose and
lipid profiles. This shows that, although crack users are
not necessarily underweight, they present other specific
nutritional deficiencies that qualify them for a diagnosis of
malnutrition. Furthermore, their condition may be asso-
ciated with other issues that deserve attention, such
as alcohol consumption and social problems. This study
is the first step towards highlighting the importance
of nutrition in the treatment of drug addiction for this
marginalized population. We intend to follow these users
and evaluate their changes in nutritional status during
recovery, as well as food intake and food-related prefer-
ences during this period.
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